Type 2 inflammation with IL-4 and IL-13 at its core creates several vicious cycles, such as continuation of epithelial barrier damage and allergen exposure to deeper tissues; growth, expansion and survival of various inflammatory cells; smooth muscle hyperplasia; mucus production; increased migration of inflammatory cells; and tissue eosinophilia. The gene discussed is IL13; the disease is Increased total eosinophil count.